Danderyds Sjukhus
Stockholm, 18288, Sweden
Location status: Recruiting
Location contact
Karl Erikson, MD, PhD
SUB_INVESTIGATOR
Olof Skoldenberg, MD, PhD
PRINCIPAL_INVESTIGATOR
Olof Skoldenberg, Md, PhD
CONTACT
NCT Number: NCT06389435
Rationale for conducting the study:
The study aims to systematically evaluate the clinical and economic impacts of Robotic-Assisted Total Knee Replacement (RTKR) compared to conventional Total Knee Replacement (TKR). It focuses on the potential benefits of RTKR, including improved precision in surgery, potentially leading to better patient outcomes and reduced healthcare costs. Our primary endpoint is the Forgotten Joint Score (FJS), aimed at measuring patients awareness of their knee joint in everyday life, indicating the success of the knee replacement surgery in restoring natural joint function. Secondary endpoints include patient-reported outcome measures (PROMs), patient activity levels, the accuracy of implant positioning on x-ray, and the incidence of adverse events.
Study design:
Multicentre,, preference-tolerant, randomized, controlled, superiority trial with two treatment arms that compares the outcomes of RTKR with traditional TKR techniques.
Study population:
Adult patients aged 18 years and older who are eligible for TKR as per local guidelines and who have given informed consent to participate in the study.
Number of patients:
400
Inclusion criteria:
Patients must be adults aged 18 years and older, eligible for TKR according to local guidelines, and willing to participate in the study.
Exclusion criteria:
Patients with extreme malalignment requiring special implants or techniques, patients unfit for surgery due to medical reasons, and those deemed unsuitable to participate in the study for other reasons.
Primary outcome variables:
The Forgotten Joint Score (FJS) at 2 years after surgery
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Stockholm, 18288, Sweden
Location status: Recruiting
Karl Erikson, MD, PhD
SUB_INVESTIGATOR
Olof Skoldenberg, MD, PhD
PRINCIPAL_INVESTIGATOR
Olof Skoldenberg, Md, PhD
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Total knee replacement (control group)
Time frame: 24 months post surgery
The primary outcome measurement will be the Forgotten Joint Score (FJS), measured at 24 months post-surgery. The FJS evaluates the patient's ability to 'forget' the artificial joint in their daily life. This scale ranges from 0 to 100, where 0 represents the maximum joint awareness and 100 represents complete joint unawareness, indicating that the patient does not perceive the joint during daily activities. Higher scores indicate a better outcome, reflecting the success of the knee replacement surgery in restoring natural joint function such that the joint feels like a natural part of the body.
Time frame: preop, 6 weeks, 12 and 24 months post surgery
The secondary outcome measure will include the Knee Injury and Osteoarthritis Outcome Score (KOOS). The KOOS is designed to assess patients' opinions about their knee and associated problems. The score comprises five separately scored subscales: Pain, Other Symptoms, Function in Daily Living (ADL), Function in Sport and Recreation (Sport/Rec), and Knee-Related Quality of Life (QOL). Each subscale is scored from 0 to 100, where 0 represents extreme knee problems and 100 represents no knee problems. Higher scores indicate a better outcome, reflecting fewer symptoms and higher levels of knee function in daily and recreational activities.
Time frame: 6 weeks, 12 and 24 months post-operation.
The self reported Activities of Daily Living Scale of the Knee Outcome Survey (ADLS) where participants will rate, over the previous 1-2 days, the degree to which slipping/partial giving way (item 1) and buckling/full giving way (item 2) of each knee affected daily activity graded from 0 (no) to 6 (severe impact on daily living)
Time frame: 6 weeks and 12 months post surgery
A secondary outcome measurement will be the Forgotten Joint Score (FJS), measured preoperatively, and at 6 weeks and 12 months post-surgery. The FJS evaluates the patient's ability to 'forget' the artificial joint in their daily life. This scale ranges from 0 to 100, where 0 represents the maximum joint awareness and 100 represents complete joint unawareness, indicating that the patient does not perceive the joint during daily activities. Higher scores indicate a better outcome, reflecting the success of the knee replacement surgery in restoring natural joint function such that the joint feels like a natural part of the body.
Time frame: 6 weeks, 12 and 24 months post surgery
A secondary outcome measure will be the European Quality of Life-5 Dimensions (EQ-5D). The EQ-5D is a standardized instrument used to measure health-related quality of life that can be utilized in a wide range of health conditions and treatments. This tool includes five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has three levels: no problems, some problems, and extreme problems. The EQ-5D index is calculated by applying a formula that attaches values to each of the levels in each dimension. This index can range from -0.594 to 1.0, where 1.0 indicates the best health state, 0 represents death, and negative values represent health states perceived as worse than death.
Time frame: 6 weeks post surgery
Knee alignment measured with long standing x-ray
Time frame: up to 24 months post surgery
Adverse events
Contact information is provided by the study sponsor or research team.
Danderyd Hospital
Other
ROCKETS: RObotic-assisted Versus Conventional Knee Endoprosthetic Techniques in a Randomized, Multicenter, Preference-tolerant Study
Acronym: ROCKETS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07009912
Arthritis, Joint Diseases
Kensington, Whangarei, New Zealand
View Trial DetailsNCT07236073
Arthritis, Joint Diseases
Erzurum, Turkey (Türkiye)
View Trial DetailsNCT05877261
Arthritis, Joint Diseases
London, Ontario, Canada
View Trial DetailsNCT06830603
Arthritis, Joint Diseases
View Trial Details